Adolor Drug Fails European Trial
71580
Adolor Corp. said on Thursday its  experimental treatment for post-operative bowel obstruction did  not confer a significant benefit in a late-stage clinical trial  in Europe, sending its stock skidding.
57452
Shares in Anglo-Swedish drug giant AstraZeneca drop more than 8% in value after the failure of its Iressa drug in a major clinical trial.
568595
AstraZeneca Plc's cholesterol-lowering  drug Crestor has been linked to the death of a patient,  Europe's third largest drugmaker said on Monday.
725490
Genelabs Technologies Inc. GNLB.O  said on Tuesday that a late-stage trial of its drug to limit  bone loss in women with lupus disease failed to work, sending  the company's shares down 75 percent.
65596
US regulators say recent newspaper ads for AstraZeneca&#39;s Crestor, a cholesterol-lowering drug, are false or misleading. An unusual letter from the Food and Drug Administration, sent Wednesday, dismissed as
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
509522
In an announcement that took doctors, patients and stock analysts by complete surprise, lung cancer drug Iressa failed to help patients live longer in a significant clinical trial.
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
182166
An anti-arthritis drug used by 84 million patients worldwide, 400,000 of them in Britain, was withdrawn from the market yesterday after trials suggested it might nearly double the risk of heart attacks and strokes.
413458
A blood pressure drug is ineffective in reducing cardiovascular deaths, research suggests.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
37828
A clinical trial of the blockbuster arthritis drug Celebrex was shut down yesterday after researchers found an increase in the risk of serious heart disease and strokes in those taking the
408507
Swiss drug maker Actelion said on Monday it would not develop its bosentan medicine, sold as Tracleer, as a treatment for metastatic melanoma, a form of skin cancer.
188476
Its unique compound to fight the growth of cancer cells fails in trials.
585919
The company withdrew its application to gain federal approval for a weight loss drug after a meeting at which government advisers rejected the treatment on safety grounds.
569835
The F.D.A. said that it would consider whether to remove Iressa, a product from AstraZeneca, from the market after the drug failed to prolong the lives of people in a clinical trial.